|
US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5985307A
(en)
|
1993-04-14 |
1999-11-16 |
Emory University |
Device and method for non-occlusive localized drug delivery
|
|
US5891108A
(en)
*
|
1994-09-12 |
1999-04-06 |
Cordis Corporation |
Drug delivery stent
|
|
US6231600B1
(en)
|
1995-02-22 |
2001-05-15 |
Scimed Life Systems, Inc. |
Stents with hybrid coating for medical devices
|
|
US6558798B2
(en)
|
1995-02-22 |
2003-05-06 |
Scimed Life Systems, Inc. |
Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
|
|
US6264684B1
(en)
|
1995-03-10 |
2001-07-24 |
Impra, Inc., A Subsidiary Of C.R. Bard, Inc. |
Helically supported graft
|
|
US6451047B2
(en)
|
1995-03-10 |
2002-09-17 |
Impra, Inc. |
Encapsulated intraluminal stent-graft and methods of making same
|
|
US6579314B1
(en)
*
|
1995-03-10 |
2003-06-17 |
C.R. Bard, Inc. |
Covered stent with encapsulated ends
|
|
US6743198B1
(en)
*
|
1995-03-20 |
2004-06-01 |
Conticare Medical, Inc. |
Self-cleansing bladder drainage device
|
|
US6099562A
(en)
*
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
US6322548B1
(en)
|
1995-05-10 |
2001-11-27 |
Eclipse Surgical Technologies |
Delivery catheter system for heart chamber
|
|
US5779673A
(en)
*
|
1995-06-26 |
1998-07-14 |
Focal, Inc. |
Devices and methods for application of intraluminal photopolymerized gels
|
|
US6302875B1
(en)
|
1996-10-11 |
2001-10-16 |
Transvascular, Inc. |
Catheters and related devices for forming passageways between blood vessels or other anatomical structures
|
|
US6283951B1
(en)
*
|
1996-10-11 |
2001-09-04 |
Transvascular, Inc. |
Systems and methods for delivering drugs to selected locations within the body
|
|
US5603694A
(en)
*
|
1995-10-17 |
1997-02-18 |
Brown; Joe E. |
Infusion coil apparatus and method for delivering fluid-based agents intravascularly
|
|
US6346510B1
(en)
|
1995-10-23 |
2002-02-12 |
The Children's Medical Center Corporation |
Therapeutic antiangiogenic endostatin compositions
|
|
US6402736B1
(en)
*
|
1996-02-16 |
2002-06-11 |
Joe E. Brown |
Apparatus and method for filtering intravascular fluids and for delivering diagnostic and therapeutic agents
|
|
SG64340A1
(en)
*
|
1996-02-27 |
1999-04-27 |
Inst Of Systems Science Nation |
Curved surgical instruments and methods of mapping a curved path for stereotactic surgery
|
|
US20040225347A1
(en)
*
|
2000-06-05 |
2004-11-11 |
Lang G. David |
Intravascular stent with increasing coating retaining capacity
|
|
US6783543B2
(en)
*
|
2000-06-05 |
2004-08-31 |
Scimed Life Systems, Inc. |
Intravascular stent with increasing coating retaining capacity
|
|
ES2248847T3
(es)
|
1996-05-24 |
2006-03-16 |
Angiotech Pharmaceuticals, Inc. |
Composiciones y metodos para tratar o prevenir enfermedades de las vias de conduccion del cuerpo.
|
|
US6190402B1
(en)
*
|
1996-06-21 |
2001-02-20 |
Musc Foundation For Research Development |
Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
|
|
US5797887A
(en)
*
|
1996-08-27 |
1998-08-25 |
Novovasc Llc |
Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
|
|
US5944701A
(en)
*
|
1996-10-03 |
1999-08-31 |
Dubrul; William R. |
Self coiling catheter
|
|
US7341598B2
(en)
*
|
1999-01-13 |
2008-03-11 |
Boston Scientific Scimed, Inc. |
Stent with protruding branch portion for bifurcated vessels
|
|
US6379334B1
(en)
*
|
1997-02-10 |
2002-04-30 |
Essex Technology, Inc. |
Rotate advance catheterization system
|
|
AU6162498A
(en)
*
|
1997-02-14 |
1998-09-08 |
Joe E. Brown |
Coil apparatus and method for delivering diagnostic and therapeutic agents intravascularly
|
|
JP3274384B2
(ja)
|
1997-03-31 |
2002-04-15 |
株式会社パイオラックス |
留置カテーテル及びその挿入装置
|
|
US6273913B1
(en)
|
1997-04-18 |
2001-08-14 |
Cordis Corporation |
Modified stent useful for delivery of drugs along stent strut
|
|
US5865815A
(en)
*
|
1997-04-25 |
1999-02-02 |
Contimed, Inc. |
Prostatic obstruction relief catheter
|
|
IT1293973B1
(it)
*
|
1997-08-13 |
1999-03-15 |
Sorin Biomedica Cardio Spa |
Elemento per l'ancoraggio in situ di dispositivi di impianto.
|
|
US6012034A
(en)
*
|
1997-08-18 |
2000-01-04 |
Becton, Dickinson And Company |
System and method for selecting an intravenous device
|
|
US20020055717A1
(en)
*
|
1997-10-20 |
2002-05-09 |
Philippe Poncet |
Fluid-based agent delivery device with self-expanding delivery element
|
|
US6168570B1
(en)
|
1997-12-05 |
2001-01-02 |
Micrus Corporation |
Micro-strand cable with enhanced radiopacity
|
|
US6241691B1
(en)
|
1997-12-05 |
2001-06-05 |
Micrus Corporation |
Coated superelastic stent
|
|
US6159165A
(en)
*
|
1997-12-05 |
2000-12-12 |
Micrus Corporation |
Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
|
|
US6358229B1
(en)
*
|
1998-02-17 |
2002-03-19 |
Conticare Medical, Inc. |
Urinary drain
|
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
|
US7208011B2
(en)
|
2001-08-20 |
2007-04-24 |
Conor Medsystems, Inc. |
Implantable medical device with drug filled holes
|
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
|
RU2140299C1
(ru)
*
|
1998-05-14 |
1999-10-27 |
Хунафин Саубан Нурлыгаянович |
Зонд
|
|
US6500149B2
(en)
|
1998-08-31 |
2002-12-31 |
Deepak Gandhi |
Apparatus for deployment of micro-coil using a catheter
|
|
US6296622B1
(en)
|
1998-12-21 |
2001-10-02 |
Micrus Corporation |
Endoluminal device delivery system using axially recovering shape memory material
|
|
US6478773B1
(en)
|
1998-12-21 |
2002-11-12 |
Micrus Corporation |
Apparatus for deployment of micro-coil using a catheter
|
|
US6358276B1
(en)
*
|
1998-09-30 |
2002-03-19 |
Impra, Inc. |
Fluid containing endoluminal stent
|
|
US6375648B1
(en)
*
|
1998-10-02 |
2002-04-23 |
Misonix Incorporated |
Infiltration cannula with teflon coated outer surface
|
|
US6048332A
(en)
*
|
1998-10-09 |
2000-04-11 |
Ave Connaught |
Dimpled porous infusion balloon
|
|
US6293967B1
(en)
|
1998-10-29 |
2001-09-25 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
|
US6214042B1
(en)
*
|
1998-11-10 |
2001-04-10 |
Precision Vascular Systems, Inc. |
Micro-machined stent for vessels, body ducts and the like
|
|
US6258118B1
(en)
|
1998-11-25 |
2001-07-10 |
Israel Aircraft Industries Ltd. |
Removable support device
|
|
US6413273B1
(en)
*
|
1998-11-25 |
2002-07-02 |
Israel Aircraft Industries Ltd. |
Method and system for temporarily supporting a tubular organ
|
|
US6348067B1
(en)
*
|
1998-11-25 |
2002-02-19 |
Israel Aircraft Industries Ltd. |
Method and system with shape memory heating apparatus for temporarily supporting a tubular organ
|
|
US6835185B2
(en)
|
1998-12-21 |
2004-12-28 |
Micrus Corporation |
Intravascular device deployment mechanism incorporating mechanical detachment
|
|
JP3524788B2
(ja)
*
|
1998-12-24 |
2004-05-10 |
株式会社パイオラックス |
制癌剤投与用体内留置カテーテル
|
|
US6398803B1
(en)
|
1999-02-02 |
2002-06-04 |
Impra, Inc., A Subsidiary Of C.R. Bard, Inc. |
Partial encapsulation of stents
|
|
US6419692B1
(en)
|
1999-02-03 |
2002-07-16 |
Scimed Life Systems, Inc. |
Surface protection method for stents and balloon catheters for drug delivery
|
|
US6398758B1
(en)
|
1999-02-16 |
2002-06-04 |
Stephen C. Jacobsen |
Medicament delivery system
|
|
US20010041870A1
(en)
*
|
1999-03-09 |
2001-11-15 |
Edward M. Gillis |
Implantable device for access to a treatment site
|
|
US6702811B2
(en)
|
1999-04-05 |
2004-03-09 |
Medtronic, Inc. |
Ablation catheter assembly with radially decreasing helix and method of use
|
|
US6595959B1
(en)
|
1999-04-23 |
2003-07-22 |
Alexander A. Stratienko |
Cardiovascular sheath/catheter
|
|
US6245045B1
(en)
|
1999-04-23 |
2001-06-12 |
Alexander Andrew Stratienko |
Combination sheath and catheter for cardiovascular use
|
|
US6514236B1
(en)
|
1999-04-23 |
2003-02-04 |
Alexander A. Stratienko |
Method for treating a cardiovascular condition
|
|
US6156373A
(en)
|
1999-05-03 |
2000-12-05 |
Scimed Life Systems, Inc. |
Medical device coating methods and devices
|
|
US6290673B1
(en)
*
|
1999-05-20 |
2001-09-18 |
Conor Medsystems, Inc. |
Expandable medical device delivery system and method
|
|
US6478778B1
(en)
*
|
1999-05-28 |
2002-11-12 |
Precision Vascular Systems, Inc. |
Apparatus for delivering fluids to blood vessels, body cavities, and the like
|
|
JP3272716B2
(ja)
*
|
1999-06-16 |
2002-04-08 |
株式会社メディテック |
カテーテル
|
|
US6368315B1
(en)
*
|
1999-06-23 |
2002-04-09 |
Durect Corporation |
Composite drug delivery catheter
|
|
US6258121B1
(en)
|
1999-07-02 |
2001-07-10 |
Scimed Life Systems, Inc. |
Stent coating
|
|
US6283947B1
(en)
|
1999-07-13 |
2001-09-04 |
Advanced Cardiovascular Systems, Inc. |
Local drug delivery injection catheter
|
|
US6494862B1
(en)
|
1999-07-13 |
2002-12-17 |
Advanced Cardiovascular Systems, Inc. |
Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway
|
|
US6350253B1
(en)
|
1999-07-19 |
2002-02-26 |
I-Flow Corporation |
Catheter for uniform delivery of medication
|
|
US7510550B2
(en)
*
|
1999-07-19 |
2009-03-31 |
I-Flow Corporation |
Catheter for uniform delivery of medication
|
|
US7452353B2
(en)
*
|
1999-07-19 |
2008-11-18 |
I-Flow Corporation |
Catheter for uniform delivery of medication
|
|
US7547302B2
(en)
*
|
1999-07-19 |
2009-06-16 |
I-Flow Corporation |
Anti-microbial catheter
|
|
US7004923B2
(en)
*
|
1999-07-19 |
2006-02-28 |
I-Flow Corporation |
Catheter for uniform delivery of medication
|
|
KR20020066320A
(ko)
*
|
1999-08-25 |
2002-08-14 |
조지타운 유니버시티 |
공동 시드, 바람직하게는 금속을 포함하여 이루어지는치료용 전달 시스템 및 이의 용도
|
|
AU7720100A
(en)
|
1999-09-27 |
2001-04-30 |
Essex Technology, Inc. |
Rotate-to-advance catheterization system
|
|
AU7839900A
(en)
|
1999-09-29 |
2001-04-30 |
Sterling Medivations, Inc. |
Reusable medication delivery device
|
|
US6596235B2
(en)
|
1999-09-30 |
2003-07-22 |
Therox, Inc. |
Method for blood oxygenation
|
|
US7544500B2
(en)
|
1999-11-13 |
2009-06-09 |
Talecris Biotherapeutics, Inc. |
Process for the production of a reversibly inactive acidified plasmin composition
|
|
EP1233716B1
(de)
|
1999-11-22 |
2014-07-30 |
Boston Scientific Limited |
Ringstrukturen für diagnostik- und therapieelemente in kontakt mit körpergeweben
|
|
US7897140B2
(en)
*
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
|
US7670327B2
(en)
*
|
2000-01-20 |
2010-03-02 |
Regents Of The University Of Minnesota |
Catheter systems for delivery of agents and related method thereof
|
|
US6663613B1
(en)
|
2000-01-25 |
2003-12-16 |
Bacchus Vascular, Inc. |
System and methods for clot dissolution
|
|
US6929633B2
(en)
|
2000-01-25 |
2005-08-16 |
Bacchus Vascular, Inc. |
Apparatus and methods for clot dissolution
|
|
US7740637B2
(en)
|
2000-02-09 |
2010-06-22 |
Micrus Endovascular Corporation |
Apparatus and method for deployment of a therapeutic device using a catheter
|
|
US6379382B1
(en)
|
2000-03-13 |
2002-04-30 |
Jun Yang |
Stent having cover with drug delivery capability
|
|
US6613082B2
(en)
|
2000-03-13 |
2003-09-02 |
Jun Yang |
Stent having cover with drug delivery capability
|
|
US7805188B2
(en)
*
|
2000-03-24 |
2010-09-28 |
Micor, Inc. |
Anesthesia conduction catheter for delivery of electrical stimulus
|
|
CA2403477C
(en)
|
2000-03-24 |
2007-07-17 |
Stephen Brushey |
Anesthesia conduction catheter
|
|
US8101200B2
(en)
*
|
2000-04-13 |
2012-01-24 |
Angiotech Biocoatings, Inc. |
Targeted therapeutic agent release devices and methods of making and using the same
|
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
|
US20040243097A1
(en)
*
|
2000-05-12 |
2004-12-02 |
Robert Falotico |
Antiproliferative drug and delivery device
|
|
US8236048B2
(en)
|
2000-05-12 |
2012-08-07 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
|
US20050002986A1
(en)
*
|
2000-05-12 |
2005-01-06 |
Robert Falotico |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
|
US7300662B2
(en)
|
2000-05-12 |
2007-11-27 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
|
US6685672B1
(en)
*
|
2000-07-13 |
2004-02-03 |
Edwards Lifesciences Corporation |
Multi-balloon drug delivery catheter for angiogenesis
|
|
AU9486901A
(en)
|
2000-09-29 |
2002-04-08 |
Cordis Corp |
Coated medical devices
|
|
US20020051730A1
(en)
*
|
2000-09-29 |
2002-05-02 |
Stanko Bodnar |
Coated medical devices and sterilization thereof
|
|
US7261735B2
(en)
*
|
2001-05-07 |
2007-08-28 |
Cordis Corporation |
Local drug delivery devices and methods for maintaining the drug coatings thereon
|
|
US20020111590A1
(en)
|
2000-09-29 |
2002-08-15 |
Davila Luis A. |
Medical devices, drug coatings and methods for maintaining the drug coatings thereon
|
|
US6764507B2
(en)
|
2000-10-16 |
2004-07-20 |
Conor Medsystems, Inc. |
Expandable medical device with improved spatial distribution
|
|
PT1328213E
(pt)
|
2000-10-16 |
2005-10-31 |
Conor Medsystems Inc |
Dispositivo medico expansivel para a administracao de um agente benefico
|
|
US6692458B2
(en)
|
2000-12-19 |
2004-02-17 |
Edwards Lifesciences Corporation |
Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis
|
|
US6964680B2
(en)
*
|
2001-02-05 |
2005-11-15 |
Conor Medsystems, Inc. |
Expandable medical device with tapered hinge
|
|
US20040073294A1
(en)
|
2002-09-20 |
2004-04-15 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
|
US7771468B2
(en)
*
|
2001-03-16 |
2010-08-10 |
Angiotech Biocoatings Corp. |
Medicated stent having multi-layer polymer coating
|
|
US6719804B2
(en)
*
|
2001-04-02 |
2004-04-13 |
Scimed Life Systems, Inc. |
Medical stent and related methods
|
|
DE10131152B4
(de)
*
|
2001-04-30 |
2004-05-27 |
Nutricia Healthcare S.A. |
Medizinisches Ballon-Button-System
|
|
US6613083B2
(en)
|
2001-05-02 |
2003-09-02 |
Eckhard Alt |
Stent device and method
|
|
US7122027B2
(en)
*
|
2001-05-25 |
2006-10-17 |
Medtronic, Inc. |
Implantable medical device with controllable gaseous agent release system
|
|
US8252040B2
(en)
|
2001-07-20 |
2012-08-28 |
Microvention, Inc. |
Aneurysm treatment device and method of use
|
|
US6629969B2
(en)
*
|
2001-07-26 |
2003-10-07 |
Durect Corporation |
Catheter for modification of agent formulation
|
|
US7364565B2
(en)
*
|
2001-07-27 |
2008-04-29 |
Ramot At Tel Aviv University Ltd. |
Controlled enzymatic removal and retrieval of cells
|
|
US7056338B2
(en)
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
|
US7842083B2
(en)
|
2001-08-20 |
2010-11-30 |
Innovational Holdings, Llc. |
Expandable medical device with improved spatial distribution
|
|
US7578841B2
(en)
|
2001-09-24 |
2009-08-25 |
Boston Scientific Scimed, Inc. |
Stent with protruding branch portion for bifurcated vessels
|
|
US7195640B2
(en)
|
2001-09-25 |
2007-03-27 |
Cordis Corporation |
Coated medical devices for the treatment of vulnerable plaque
|
|
US20030065345A1
(en)
*
|
2001-09-28 |
2003-04-03 |
Kevin Weadock |
Anastomosis devices and methods for treating anastomotic sites
|
|
US20030065377A1
(en)
*
|
2001-09-28 |
2003-04-03 |
Davila Luis A. |
Coated medical devices
|
|
US7108701B2
(en)
|
2001-09-28 |
2006-09-19 |
Ethicon, Inc. |
Drug releasing anastomosis devices and methods for treating anastomotic sites
|
|
US20050065118A1
(en)
*
|
2001-10-16 |
2005-03-24 |
Jing Wang |
Organosulfur inhibitors of tyrosine phosphatases
|
|
US6620202B2
(en)
|
2001-10-16 |
2003-09-16 |
Scimed Life Systems, Inc. |
Medical stent with variable coil and related methods
|
|
US6936040B2
(en)
*
|
2001-10-29 |
2005-08-30 |
Medtronic, Inc. |
Method and apparatus for endovenous pacing lead
|
|
US7438710B2
(en)
*
|
2001-11-07 |
2008-10-21 |
Anderson Kent D |
Distal protection device with local drug infusion by physician to maintain patency
|
|
US7041139B2
(en)
|
2001-12-11 |
2006-05-09 |
Boston Scientific Scimed, Inc. |
Ureteral stents and related methods
|
|
US7364757B2
(en)
*
|
2002-02-13 |
2008-04-29 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Methods of treating vascular disease
|
|
US8506647B2
(en)
*
|
2002-02-14 |
2013-08-13 |
Boston Scientific Scimed, Inc. |
System for maintaining body canal patency
|
|
US8328877B2
(en)
|
2002-03-19 |
2012-12-11 |
Boston Scientific Scimed, Inc. |
Stent retention element and related methods
|
|
US20030191453A1
(en)
*
|
2002-04-03 |
2003-10-09 |
Velez Omar E. |
Catheter assembly
|
|
US8150519B2
(en)
|
2002-04-08 |
2012-04-03 |
Ardian, Inc. |
Methods and apparatus for bilateral renal neuromodulation
|
|
US20080213331A1
(en)
|
2002-04-08 |
2008-09-04 |
Ardian, Inc. |
Methods and devices for renal nerve blocking
|
|
US7853333B2
(en)
|
2002-04-08 |
2010-12-14 |
Ardian, Inc. |
Methods and apparatus for multi-vessel renal neuromodulation
|
|
US20140018880A1
(en)
|
2002-04-08 |
2014-01-16 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for monopolar renal neuromodulation
|
|
US20070129761A1
(en)
|
2002-04-08 |
2007-06-07 |
Ardian, Inc. |
Methods for treating heart arrhythmia
|
|
US9636174B2
(en)
|
2002-04-08 |
2017-05-02 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods for therapeutic renal neuromodulation
|
|
US7653438B2
(en)
|
2002-04-08 |
2010-01-26 |
Ardian, Inc. |
Methods and apparatus for renal neuromodulation
|
|
US8774913B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for intravasculary-induced neuromodulation
|
|
US20070135875A1
(en)
|
2002-04-08 |
2007-06-14 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
|
US7617005B2
(en)
|
2002-04-08 |
2009-11-10 |
Ardian, Inc. |
Methods and apparatus for thermally-induced renal neuromodulation
|
|
JP2005522521A
(ja)
|
2002-04-15 |
2005-07-28 |
ベス イスラエル デアコネス メディカル センター |
ヘムオキシゲナーゼ−１およびヘム分解産物の使用法
|
|
US7122048B2
(en)
*
|
2002-05-03 |
2006-10-17 |
Scimed Life Systems, Inc. |
Hypotube endoluminal device
|
|
US8829198B2
(en)
|
2007-10-31 |
2014-09-09 |
Proteotech Inc |
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
|
|
CA2490392A1
(en)
*
|
2002-06-21 |
2003-12-31 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
|
|
AU2003248747A1
(en)
|
2002-06-27 |
2004-01-19 |
Health Research, Inc. |
Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
|
|
WO2004005289A2
(en)
*
|
2002-07-02 |
2004-01-15 |
Health Research, Inc. |
Efficient synthesis of pyropheophorbide a and its derivatives
|
|
CA2484383C
(en)
*
|
2002-07-12 |
2016-05-31 |
Cook Incorporated |
Medical device coated with a bioactive agent
|
|
JP3887588B2
(ja)
*
|
2002-08-30 |
2007-02-28 |
株式会社リガク |
Ｘ線回折による応力測定法
|
|
US20040127976A1
(en)
*
|
2002-09-20 |
2004-07-01 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
|
US20040059228A1
(en)
*
|
2002-09-23 |
2004-03-25 |
Scimed Life Systems, Inc. |
Systems and methods for flushing catheters
|
|
AU2003290806A1
(en)
*
|
2002-11-15 |
2004-06-15 |
The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services |
Variable curve catheter
|
|
AU2004226327A1
(en)
|
2003-03-28 |
2004-10-14 |
Innovational Holdings, Llc |
Implantable medical device with beneficial agent concentration gradient
|
|
US20040242886A1
(en)
*
|
2003-04-30 |
2004-12-02 |
Sandeep Gupta |
Monocyclic diazodioxide based Bcl-2 protein antagonists related applications
|
|
WO2004099162A1
(en)
*
|
2003-04-30 |
2004-11-18 |
Ricerca Biosciences, Llc. |
Polycyclic diazodioxide-based bcl-2 protein antagonist
|
|
ATE476960T1
(de)
*
|
2003-05-02 |
2010-08-15 |
Surmodics Inc |
System zur kontrollierten freisetzung eines bioaktiven wirkstoffs im hinteren bereich des auges
|
|
EP1628666B1
(de)
*
|
2003-05-14 |
2015-09-23 |
NeuroGenetic Pharmaceuticals, Inc. |
Verbindungen und ihre verwendungen zur modulierung von amyloid beta
|
|
US8916598B2
(en)
|
2003-05-30 |
2014-12-23 |
Proteotech Inc |
Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
|
|
US20040249364A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Ilya Kaploun |
Device and method for dispensing medication to tissue lining a body cavity
|
|
US7169179B2
(en)
*
|
2003-06-05 |
2007-01-30 |
Conor Medsystems, Inc. |
Drug delivery device and method for bi-directional drug delivery
|
|
US20040260271A1
(en)
*
|
2003-06-18 |
2004-12-23 |
Huyser Richard F. |
Extended fenestration catheter with internal coil and method of making the same
|
|
US7057100B2
(en)
*
|
2003-06-26 |
2006-06-06 |
The J.C. Robinson Seed Co. |
Inbred corn line W23129
|
|
US7785653B2
(en)
|
2003-09-22 |
2010-08-31 |
Innovational Holdings Llc |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
|
US20050101938A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Leiboff Arnold R. |
Guidewire for use in colonic irrigation
|
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
|
JP2007538103A
(ja)
|
2004-05-20 |
2007-12-27 |
ザ スクリップス リサーチ インスティテュート |
トランスサイレチン安定化
|
|
EP1765332A2
(de)
*
|
2004-06-17 |
2007-03-28 |
Cengent Therapeutics, Inc. |
Trisubstituierte stickstoffmodulatoren von tyrosin-phosphatasen
|
|
WO2006017124A2
(en)
*
|
2004-07-09 |
2006-02-16 |
Cengent Therapeutics, Inc. |
Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
|
|
FR2873016B1
(fr)
*
|
2004-07-15 |
2006-09-29 |
Pierre Marcel Bourgogne |
Protheses vasculaires artificielles delivrant en permanence des produits actifs empechant toute stenose, thrombose, proliferation cellulaire, etc.. d'acces aise permanent pour toute intervention
|
|
JP2008510726A
(ja)
*
|
2004-08-20 |
2008-04-10 |
エントレメッド インコーポレイテッド |
プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法
|
|
WO2006028970A1
(en)
|
2004-09-02 |
2006-03-16 |
Cengent Therapeutics, Inc. |
Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
|
|
NZ588432A
(en)
|
2004-09-17 |
2012-03-30 |
Whitehead Biomedical Inst |
Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
|
|
US20060067889A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Light Sciences Corporation |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
|
|
US20080140187A1
(en)
*
|
2004-10-15 |
2008-06-12 |
Krause Arthur A |
Anti-clotting, anti-microbial, anti-inflammatory medical stent
|
|
CN101076290B
(zh)
|
2004-12-09 |
2011-11-23 |
铸造品股份有限公司 |
主动脉瓣修复
|
|
US8983582B2
(en)
*
|
2004-12-20 |
2015-03-17 |
Advanced Cardiovascular Systems, Inc. |
Methods and apparatuses for positioning within an internal channel
|
|
EP1861133B1
(de)
|
2005-02-28 |
2012-11-21 |
Spirus Medical Inc. |
System zur Katheterisierung durch drehende Einführung
|
|
EP1866319B1
(de)
|
2005-04-01 |
2011-11-23 |
The Regents of The University of California |
Phosphono-pent-2-en-1-yl-nukleoside und analoga
|
|
US20090156545A1
(en)
*
|
2005-04-01 |
2009-06-18 |
Hostetler Karl Y |
Substituted Phosphate Esters of Nucleoside Phosphonates
|
|
US20060229573A1
(en)
*
|
2005-04-08 |
2006-10-12 |
Mckinley Medical L.L.L.P. |
Adjustable infusion catheter
|
|
US8317678B2
(en)
|
2005-05-04 |
2012-11-27 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
|
US8235942B2
(en)
|
2005-05-04 |
2012-08-07 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
|
US8414477B2
(en)
|
2005-05-04 |
2013-04-09 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
|
US8343040B2
(en)
|
2005-05-04 |
2013-01-01 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
|
US7780650B2
(en)
|
2005-05-04 |
2010-08-24 |
Spirus Medical, Inc. |
Rotate-to-advance catheterization system
|
|
US7396366B2
(en)
|
2005-05-11 |
2008-07-08 |
Boston Scientific Scimed, Inc. |
Ureteral stent with conforming retention structure
|
|
WO2007002109A2
(en)
*
|
2005-06-20 |
2007-01-04 |
The Regents Of The University Of California |
Multidentate pyrone-derived chelators for medicinal imaging and chelation
|
|
US9162033B2
(en)
*
|
2005-06-27 |
2015-10-20 |
Cook Medical Technologies Llc |
Dilator for performing a percutaneous medical procedure
|
|
US20070031611A1
(en)
*
|
2005-08-04 |
2007-02-08 |
Babaev Eilaz P |
Ultrasound medical stent coating method and device
|
|
US9101949B2
(en)
*
|
2005-08-04 |
2015-08-11 |
Eilaz Babaev |
Ultrasonic atomization and/or seperation system
|
|
EP1933810B1
(de)
|
2005-08-11 |
2012-10-10 |
Massachusetts Institute of Technology |
Vorrichtung und verfahren für intravesikale wirkstofffreisetzung
|
|
US7896539B2
(en)
*
|
2005-08-16 |
2011-03-01 |
Bacoustics, Llc |
Ultrasound apparatus and methods for mixing liquids and coating stents
|
|
US8492428B2
(en)
*
|
2005-09-20 |
2013-07-23 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
|
US7540881B2
(en)
*
|
2005-12-22 |
2009-06-02 |
Boston Scientific Scimed, Inc. |
Bifurcation stent pattern
|
|
US8138361B2
(en)
*
|
2005-12-28 |
2012-03-20 |
The Trustees Of The University Of Pennsylvania |
C-10 carbamates of taxanes
|
|
US8435229B2
(en)
|
2006-02-28 |
2013-05-07 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
|
US8574220B2
(en)
|
2006-02-28 |
2013-11-05 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
|
WO2007106537A2
(en)
*
|
2006-03-13 |
2007-09-20 |
Activx Biosciences, Inc. |
Aminoquinolones as gsk-3 inhibitors
|
|
EP2007373A4
(de)
*
|
2006-03-29 |
2012-12-19 |
Foldrx Pharmaceuticals Inc |
Hemmung der alpha-synuclein-toxizität
|
|
US20090318886A1
(en)
*
|
2006-04-27 |
2009-12-24 |
Anna Norlin |
Medical device
|
|
EA021255B1
(ru)
|
2006-08-28 |
2015-05-29 |
Киова Хакко Кирин Ко., Лимитед |
Антагонистические моноклональные антитела человека, специфичные в отношении light человека
|
|
US7547323B2
(en)
*
|
2006-08-29 |
2009-06-16 |
Sinexus, Inc. |
Stent for irrigation and delivery of medication
|
|
CN101535304A
(zh)
|
2006-09-21 |
2009-09-16 |
埃迪威克斯生物科学公司 |
丝氨酸水解酶抑制剂
|
|
US20080082083A1
(en)
*
|
2006-09-28 |
2008-04-03 |
Forde Sean T |
Perforated expandable implant recovery sheath
|
|
US7951191B2
(en)
*
|
2006-10-10 |
2011-05-31 |
Boston Scientific Scimed, Inc. |
Bifurcated stent with entire circumferential petal
|
|
US20080140176A1
(en)
*
|
2006-10-18 |
2008-06-12 |
Krause Arthur A |
Medical stent and devices for localized treatment of disease
|
|
BRPI0715579A2
(pt)
|
2006-10-19 |
2015-05-26 |
Auspex Pharmaceuticals Inc |
"composto, composição farmacêutica e uso de um composto"
|
|
US8287519B2
(en)
*
|
2006-10-27 |
2012-10-16 |
Smith Tech Innovations, Llc |
Self-cleansing bladder drainage catheter
|
|
WO2008057604A2
(en)
*
|
2006-11-08 |
2008-05-15 |
The Regents Of The University Of California |
Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
|
|
US7842082B2
(en)
*
|
2006-11-16 |
2010-11-30 |
Boston Scientific Scimed, Inc. |
Bifurcated stent
|
|
WO2008070769A1
(en)
*
|
2006-12-06 |
2008-06-12 |
Medtronic, Inc. |
Intrathecal catheter
|
|
US20080142616A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Bacoustics Llc |
Method of Producing a Directed Spray
|
|
US20080146605A1
(en)
|
2006-12-19 |
2008-06-19 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of ccr5 inhibitors
|
|
WO2008079371A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Encysive Pharmaceuticals, Inc. |
Modulators of c3a receptor and methods of use thereof
|
|
BRPI0808089A2
(pt)
*
|
2007-02-28 |
2014-07-15 |
Conatus Pharmaceuticals Inc |
Método para tratar uma doença do fígado, para diminuir um nível elevado de uma enzima do fígado, para inibir uma cascata de sinalização de tnf-alfa e uma cascata de sinalização de alfa-faz, para reduzir um dano ao fígado, para suprimir a apoptose excessiva em uma célula de fígado, e para inibir a replicação do vírus da hepatite c.
|
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
|
ES2693948T3
(es)
|
2007-03-15 |
2018-12-14 |
Auspex Pharmaceuticals, Inc. |
Fenetilamina sustituida con actividad serotoninérgica y/o norepinefrinérgica
|
|
US8827979B2
(en)
|
2007-03-19 |
2014-09-09 |
Insuline Medical Ltd. |
Drug delivery device
|
|
US8622991B2
(en)
|
2007-03-19 |
2014-01-07 |
Insuline Medical Ltd. |
Method and device for drug delivery
|
|
US9220837B2
(en)
|
2007-03-19 |
2015-12-29 |
Insuline Medical Ltd. |
Method and device for drug delivery
|
|
WO2008122048A2
(en)
*
|
2007-04-02 |
2008-10-09 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Removal of contrast agents from blood
|
|
US7892776B2
(en)
|
2007-05-04 |
2011-02-22 |
The Regents Of The University Of California |
Screening assay to identify modulators of protein kinase A
|
|
US20080281291A1
(en)
*
|
2007-05-07 |
2008-11-13 |
Claude Tihon |
Drainage/irrigation urethral catheter
|
|
US20120149985A1
(en)
*
|
2007-05-18 |
2012-06-14 |
Frassica James J |
Rotate-to-advance catheterization system
|
|
US8870755B2
(en)
|
2007-05-18 |
2014-10-28 |
Olympus Endo Technology America Inc. |
Rotate-to-advance catheterization system
|
|
US8721711B2
(en)
*
|
2007-06-20 |
2014-05-13 |
Oregon Health & Science University |
Graft having microporous membrane for uniform fluid infusion
|
|
EP2162101B1
(de)
|
2007-06-25 |
2019-02-20 |
MicroVention, Inc. |
Selbstexpandierende prothese
|
|
US9402973B2
(en)
|
2007-07-06 |
2016-08-02 |
Vital 5, Llc |
Constrained fluid delivery device
|
|
MX2010000465A
(es)
*
|
2007-07-12 |
2010-08-30 |
Tragara Pharmaceuticals Inc |
Metodos y composiciones para el tratamiento de cancer, tumores y alteraciones relacionadas con tumores.
|
|
US7780095B2
(en)
|
2007-07-13 |
2010-08-24 |
Bacoustics, Llc |
Ultrasound pumping apparatus
|
|
US7753285B2
(en)
|
2007-07-13 |
2010-07-13 |
Bacoustics, Llc |
Echoing ultrasound atomization and/or mixing system
|
|
CN101855228B
(zh)
*
|
2007-09-11 |
2012-10-24 |
杏林制药株式会社 |
作为gsk-3抑制剂的氰基氨基喹诺酮和四唑并氨基喹诺酮
|
|
US8476261B2
(en)
|
2007-09-12 |
2013-07-02 |
Kyorin Pharmaceutical Co., Ltd. |
Spirocyclic aminoquinolones as GSK-3 inhibitors
|
|
US7959669B2
(en)
*
|
2007-09-12 |
2011-06-14 |
Boston Scientific Scimed, Inc. |
Bifurcated stent with open ended side branch support
|
|
US8100855B2
(en)
*
|
2007-09-17 |
2012-01-24 |
Abbott Cardiovascular Systems, Inc. |
Methods and devices for eluting agents to a vessel
|
|
US20090076591A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Boston Scientific Scimed, Inc. |
Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface
|
|
US20090264421A1
(en)
*
|
2007-10-05 |
2009-10-22 |
Bible Keith C |
Methods and Compositions for Treating Cancer
|
|
JP5476515B2
(ja)
*
|
2007-10-09 |
2014-04-23 |
ユニヴェルシテ・パリ・デカルト |
細胞を投与するデバイス
|
|
CA2706465A1
(en)
|
2007-11-21 |
2009-05-28 |
Pharmaxis Ltd. |
Haloallylamine inhibitors of ssao/vap-1 and uses therefor
|
|
US7833266B2
(en)
|
2007-11-28 |
2010-11-16 |
Boston Scientific Scimed, Inc. |
Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
|
|
EA201070703A1
(ru)
|
2007-12-11 |
2010-12-30 |
Массачусетс Инститьют Оф Текнолоджи |
Имплантируемое устройство для доставки лекарства и способы лечения мочевого пузыря и других полостей тела или трубчатых органов
|
|
US8808255B2
(en)
*
|
2007-12-14 |
2014-08-19 |
Oregon Health & Science University |
Drug delivery cuff
|
|
US8409133B2
(en)
|
2007-12-18 |
2013-04-02 |
Insuline Medical Ltd. |
Drug delivery device with sensor for closed-loop operation
|
|
US8277501B2
(en)
*
|
2007-12-21 |
2012-10-02 |
Boston Scientific Scimed, Inc. |
Bi-stable bifurcated stent petal geometry
|
|
US8221494B2
(en)
|
2008-02-22 |
2012-07-17 |
Endologix, Inc. |
Apparatus and method of placement of a graft or graft system
|
|
US8196279B2
(en)
|
2008-02-27 |
2012-06-12 |
C. R. Bard, Inc. |
Stent-graft covering process
|
|
WO2009111611A2
(en)
*
|
2008-03-05 |
2009-09-11 |
Proteotech Inc. |
Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
|
|
PL2947072T3
(pl)
|
2008-03-17 |
2017-05-31 |
Ambit Biosciences Corporation |
1-(3-(6,7-dimetoksychinazolin-4-yloksy)fenylo)-3-(5-(1,1,1-trifluoro-2-metylopropan-2-ylo)izoksazol-3-ilo)mocznik jako modulator kinazy RAF w leczeniu chorób nowotworowych
|
|
US20090240318A1
(en)
*
|
2008-03-19 |
2009-09-24 |
Boston Scientific Scimed, Inc. |
Stent expansion column, strut and connector slit design
|
|
US20090275918A1
(en)
*
|
2008-05-01 |
2009-11-05 |
Stemcor Systems, Inc. |
Pancreatic delivery catheter
|
|
US8932340B2
(en)
*
|
2008-05-29 |
2015-01-13 |
Boston Scientific Scimed, Inc. |
Bifurcated stent and delivery system
|
|
NZ589557A
(en)
|
2008-06-04 |
2012-08-31 |
Talecris Biotherapeutics Inc |
Immobilised streptokinase, method and kit for preparing plasmin
|
|
EA201170297A1
(ru)
|
2008-08-09 |
2011-08-30 |
Массачусетс Инститьют Оф Текнолоджи |
Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
|
|
US20120034155A1
(en)
*
|
2010-08-03 |
2012-02-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Artificial cells
|
|
CN101658533A
(zh)
*
|
2008-08-29 |
2010-03-03 |
首都医科大学宣武医院 |
抗肿瘤药物的干细胞递送
|
|
US8187222B2
(en)
*
|
2008-09-12 |
2012-05-29 |
Boston Scientific Scimed, Inc. |
Devices and systems for delivery of therapeutic agents to body lumens
|
|
WO2010036541A1
(en)
*
|
2008-09-24 |
2010-04-01 |
Cook Incorporated |
Catheter system having variable stiffness
|
|
WO2010041084A1
(en)
*
|
2008-10-09 |
2010-04-15 |
Plethora Solutions Ltd |
Medical device
|
|
WO2010059364A2
(en)
*
|
2008-10-30 |
2010-05-27 |
Epitek, Inc. |
Method and apparatus for sub-xiphoid delivery of therapeutic agents
|
|
EP2355758A2
(de)
|
2008-11-07 |
2011-08-17 |
Insuline Medical Ltd. |
Arzneimittelabgabevorrichtung und -verfahren
|
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
|
US8568793B2
(en)
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
|
PL2401267T3
(pl)
*
|
2009-02-27 |
2014-06-30 |
Ambit Biosciences Corp |
Pochodne chinazoliny modulujące kinazę JAK i ich zastosowanie w metodach
|
|
HUE025670T2
(en)
|
2009-03-03 |
2016-04-28 |
Grifols Therapeutics Inc |
A method for producing plasminogen
|
|
JP5690286B2
(ja)
|
2009-03-04 |
2015-03-25 |
イデニク プハルマセウティカルス，インコーポレイテッド |
ホスホチオフェン及びホスホチアゾールｈｃｖポリメラーゼ阻害剤
|
|
JP2012520314A
(ja)
|
2009-03-11 |
2012-09-06 |
アムビト ビオスシエンセス コルポラチオン |
癌治療のためのインダゾリルアミノピロロトリアジンとタキサンの併用
|
|
KR101748891B1
(ko)
*
|
2009-03-11 |
2017-06-19 |
교린 세이야꾸 가부시키 가이샤 |
Ｇｓｋ-3 억제제로서의 7-시클로알킬아미노퀴놀론
|
|
AU2010229468A1
(en)
|
2009-03-27 |
2011-10-13 |
Vetdc, Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
|
WO2010110686A1
(en)
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics Limited |
Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
|
|
SG175748A1
(en)
|
2009-04-22 |
2011-12-29 |
Axikin Pharmaceuticals Inc |
2,5-disubstituted arylsulfonamide ccr3 antagonists
|
|
PE20120810A1
(es)
|
2009-04-22 |
2012-07-08 |
Axikin Pharmaceuticals Inc |
Compuestos derivados de 5-ciano-2-(feniltio)bencensulfonamida como antagonistas de ccr3
|
|
AR076363A1
(es)
|
2009-04-22 |
2011-06-08 |
Axikin Pharmaceuticals Inc |
Antagonistas de ccr3 de arilsulfonamida
|
|
US8945202B2
(en)
|
2009-04-28 |
2015-02-03 |
Endologix, Inc. |
Fenestrated prosthesis
|
|
US20100292641A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Bandula Wijay |
Targeted drug delivery device and method
|
|
CA2765630C
(en)
|
2009-06-26 |
2016-07-05 |
Taris Biomedical, Inc. |
Solid drug tablets for implantable drug delivery devices
|
|
WO2011003870A2
(en)
|
2009-07-06 |
2011-01-13 |
Creabilis S.A. |
Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
|
|
US8486939B2
(en)
|
2009-07-07 |
2013-07-16 |
Pathway Therapeutics Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
|
ES2655883T5
(es)
|
2009-07-08 |
2022-04-18 |
Hope Medical Entpr Inc D B A Hope Pharmaceuticals |
Composiciones farmacéuticas que contienen tiosulfato de sodio
|
|
US20110022026A1
(en)
*
|
2009-07-21 |
2011-01-27 |
Lake Region Manufacturing, Inc. d/b/a Lake Region Medical. Inc. |
Methods and Devices for Delivering Drugs Using Drug-Delivery or Drug-Coated Guidewires
|
|
US8404728B2
(en)
|
2009-07-30 |
2013-03-26 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
|
US9284307B2
(en)
|
2009-08-05 |
2016-03-15 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors
|
|
BR112012003661A2
(pt)
|
2009-08-19 |
2017-04-25 |
Ambit Biosciences Corp |
"compostos de biarila e métodos de uso dos mesmos."
|
|
US9017312B2
(en)
|
2009-09-10 |
2015-04-28 |
Taris Biomedical Llc |
Implantable device for controlled drug delivery
|
|
TW201120037A
(en)
|
2009-10-26 |
2011-06-16 |
Sunesis Pharmaceuticals Inc |
Compounds and methods for treatment of cancer
|
|
WO2011056764A1
(en)
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
|
WO2011057214A2
(en)
|
2009-11-09 |
2011-05-12 |
Neurogenetic Pharmaceuticals, Inc. |
Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
|
|
US20110301235A1
(en)
|
2009-12-02 |
2011-12-08 |
Alquest Therapeutics, Inc. |
Organoselenium compounds and uses thereof
|
|
SG181797A1
(en)
|
2009-12-18 |
2012-07-30 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
|
EP2515654A4
(de)
*
|
2009-12-23 |
2013-04-24 |
Map Pharmaceuticals Inc |
Neue ergolinanaloga
|
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
|
EP2542542B1
(de)
|
2010-03-02 |
2015-04-22 |
Axikin Pharmaceuticals, Inc. |
Isotopisch angereicherte arylsulfonamid-ccr3-antagonisten
|
|
WO2011112689A2
(en)
|
2010-03-11 |
2011-09-15 |
Ambit Biosciences Corp. |
Saltz of an indazolylpyrrolotriazine
|
|
WO2011116161A2
(en)
|
2010-03-17 |
2011-09-22 |
Axikin Pharmaceuticals Inc. |
Arylsulfonamide ccr3 antagonists
|
|
EP2566558B1
(de)
*
|
2010-05-05 |
2019-04-17 |
Cook Medical Technologies LLC |
Intraluminale behandlungsvorrichtung, drahtführung und verfahren zur freisetzung einer behandlungsflüssigkeit
|
|
WO2011140186A1
(en)
*
|
2010-05-05 |
2011-11-10 |
Cook Medical Technologies Llc |
Treatment fluid delivery method, and turbulator for promoting uptake of a treatment agent
|
|
US9265913B2
(en)
|
2010-09-22 |
2016-02-23 |
Vital 5, Llc |
Catheter assembly
|
|
WO2011150201A2
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl amide compounds and methods of use thereof
|
|
WO2011150198A1
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl urea compounds and methods of use thereof
|
|
WO2011153197A1
(en)
|
2010-06-01 |
2011-12-08 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
|
|
CA2801003A1
(en)
|
2010-06-01 |
2011-12-08 |
Biotheryx, Inc. |
Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone
|
|
NZ604018A
(en)
|
2010-06-07 |
2015-02-27 |
Novomedix Llc |
Furanyl compounds and the use thereof
|
|
EP2585455B1
(de)
|
2010-06-24 |
2019-08-07 |
The Regents of the University of California |
Verbindungen und ihre verwendung bei der modulation der konzentrationen verschiedener amyloid-beta-peptid-alloformen
|
|
US20140200270A1
(en)
|
2013-01-11 |
2014-07-17 |
Summa Health System |
Vitamins c and k for treating polycystic diseases
|
|
MX347927B
(es)
|
2010-07-19 |
2017-05-19 |
Summa Health System |
Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb.
|
|
US8912324B2
(en)
|
2010-09-01 |
2014-12-16 |
Ambit Biosciences Corporation |
Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
|
|
WO2012030912A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
|
EP2611502A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Adenosin-a3-rezeptormodulierende verbindungen und ihre verwendung
|
|
US20130296363A1
(en)
|
2010-09-01 |
2013-11-07 |
Ambit Biosciences Corporation |
Quinoline and isoquinoline derivatives for use as jak modulators
|
|
WO2012030910A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
2-cycloquinazoline derivatives and methods of use thereof
|
|
EP2611792B1
(de)
|
2010-09-01 |
2017-02-01 |
Ambit Biosciences Corporation |
Hydrobromid salze einer pyrazolylaminoquinazolin
|
|
EP2611812A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Thienopyridin- und thienopyrimidinverbindungen sowie verfahren zu ihrer verwendung
|
|
WO2012030914A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Boisciences Corporation |
4-azolylaminoquinazoline derivatives and methods of use thereof
|
|
US20130303533A1
(en)
|
2010-09-01 |
2013-11-14 |
Ambit Biosciences Corporation |
Azolopyridine and azolopyrimidine compounds and methods of use thereof
|
|
AU2011296024B2
(en)
|
2010-09-01 |
2015-05-28 |
Ambit Biosciences Corporation |
Quinazoline compounds and methods of use thereof
|
|
US9446224B2
(en)
|
2010-09-22 |
2016-09-20 |
Vital 5, L.L.C. |
Barrier catheter
|
|
IT1402059B1
(it)
*
|
2010-09-29 |
2013-08-28 |
Rand Srl |
Sistema indossabile per eseguire terapie depurative di fluidi organici con l'impiego di circuiti extracorporei
|
|
WO2012044641A1
(en)
|
2010-09-29 |
2012-04-05 |
Pathway Therapeutics Inc. |
1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
|
US20120088769A1
(en)
|
2010-10-11 |
2012-04-12 |
Axikin Pharmaceuticals, Inc. |
Salts of arylsulfonamide ccr3 antagonists
|
|
US9084610B2
(en)
|
2010-10-21 |
2015-07-21 |
Medtronic Ardian Luxembourg S.A.R.L. |
Catheter apparatuses, systems, and methods for renal neuromodulation
|
|
CN202654229U
(zh)
|
2010-10-25 |
2013-01-09 |
美敦力Af卢森堡有限责任公司 |
用于通过肾去神经支配治疗人类患者的导管装置
|
|
US20120109279A1
(en)
|
2010-11-02 |
2012-05-03 |
Endologix, Inc. |
Apparatus and method of placement of a graft or graft system
|
|
WO2012078649A1
(en)
|
2010-12-06 |
2012-06-14 |
Follica, Inc. |
Methods for treating baldness and promoting hair growth
|
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
|
JP2014503554A
(ja)
|
2011-01-10 |
2014-02-13 |
タリス バイオメディカル，インコーポレイテッド |
膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン
|
|
EP3763740A1
(de)
|
2011-01-26 |
2021-01-13 |
Celldex Therapeutics, Inc. |
Anti-kit-antikörper und verwendungen davon
|
|
US10052459B2
(en)
*
|
2011-01-28 |
2018-08-21 |
Cook Medical Technologies Llc |
Catheter assembly and method
|
|
JP2014503597A
(ja)
|
2011-01-31 |
2014-02-13 |
セルジーン コーポレイション |
シチジンアナログの医薬組成物及びその使用方法
|
|
ES2637388T3
(es)
|
2011-02-04 |
2017-10-13 |
Taris Biomedical, Inc. |
Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad
|
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
|
US20140088103A1
(en)
|
2011-03-28 |
2014-03-27 |
Mei Pharma, Inc. |
(fused ring arylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
|
EP2691384B1
(de)
|
2011-03-28 |
2016-10-26 |
MEI Pharma, Inc. |
(alpha-substituierte aralkylamino- und heteroaralkylamino)-pyrimidinyl- und 1,3,5-triazinyl-benzimidazoles, sie enthaltende pharmazeutische zusammensetzungen und diese verbindungen zur verwendung bei der behandlung proliferativer erkrankungen
|
|
AU2012236722A1
(en)
|
2011-03-28 |
2013-10-17 |
Mei Pharma, Inc. |
(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
|
US11166660B2
(en)
*
|
2011-04-05 |
2021-11-09 |
Pharmasens Ag |
Dermally affixed device for intravenous access
|
|
EP2694150A1
(de)
|
2011-04-08 |
2014-02-12 |
Covidien LP |
Iontophorese-medikamentenabgabesystem sowie verfahren zur denervierung der renalen sympathischen nerven und iontophorese-medikamentenabgabe
|
|
US10786242B2
(en)
*
|
2011-04-20 |
2020-09-29 |
Kinamed, Inc. |
Shapeable passer for surgical cable or suture
|
|
EP2723735A4
(de)
|
2011-06-23 |
2015-02-18 |
Map Pharmaceuticals Inc |
Neue fluorergolin-analoga
|
|
WO2013022005A1
(ja)
*
|
2011-08-08 |
2013-02-14 |
オリンパスメディカルシステムズ株式会社 |
処置具
|
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
|
USD679804S1
(en)
|
2011-09-22 |
2013-04-09 |
Vital 5, Llc |
Catheter
|
|
US20130085468A1
(en)
*
|
2011-10-03 |
2013-04-04 |
Yuri Buydenok |
Catheter with body wall separator
|
|
MY167575A
(en)
|
2011-10-14 |
2018-09-20 |
Ambit Biosciences Corp |
Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
|
|
AU2012355982A1
(en)
|
2011-12-19 |
2014-07-10 |
Map Pharmaceuticals, Inc. |
Novel iso-ergoline derivatives
|
|
US8946420B2
(en)
|
2011-12-21 |
2015-02-03 |
Map Pharmaceuticals, Inc. |
Neuromodulatory compounds
|
|
WO2013130600A1
(en)
|
2012-02-29 |
2013-09-06 |
Ambit Biosciences Corporation |
Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
|
|
TW201341367A
(zh)
|
2012-03-16 |
2013-10-16 |
Axikin Pharmaceuticals Inc |
３，５－二胺基吡唑激酶抑制劑
|
|
US9044581B2
(en)
*
|
2012-03-19 |
2015-06-02 |
Cook Medical Technologies Llc |
Medical devices, methods, and kits for delivering medication to a bodily passage
|
|
US10258791B2
(en)
|
2012-04-27 |
2019-04-16 |
Medtronic Ardian Luxembourg S.A.R.L. |
Catheter assemblies for neuromodulation proximate a bifurcation of a renal artery and associated systems and methods
|
|
SI2844637T1
(en)
|
2012-05-02 |
2018-07-31 |
Boehringer Ingelheim International Gmbh |
Substituted 3-haloallylamine inhibitors of ssao and uses thereof
|
|
EP2846724B1
(de)
|
2012-05-11 |
2016-11-09 |
Medtronic Ardian Luxembourg S.à.r.l. |
Multielektrodenkatheteranordnungen zur renalen neuromodulation sowie zugehörige systeme
|
|
US9732038B2
(en)
|
2012-06-14 |
2017-08-15 |
Mayo Foundation For Medical Education And Research |
Pyrazole derivatives as inhibitors of STAT3
|
|
US9381326B2
(en)
*
|
2012-06-15 |
2016-07-05 |
W. L. Gore & Associates, Inc. |
Vascular occlusion and drug delivery devices, systems, and methods
|
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|
|
CN104812775B
(zh)
|
2012-07-25 |
2019-05-03 |
塞尔德克斯医疗公司 |
抗kit抗体及其用途
|
|
US9074186B2
(en)
|
2012-08-15 |
2015-07-07 |
Boston Medical Center Corporation |
Production of red blood cells and platelets from stem cells
|
|
US9156799B2
(en)
|
2012-09-07 |
2015-10-13 |
Axikin Pharmaceuticals, Inc. |
Isotopically enriched arylsulfonamide CCR3 antagonists
|
|
WO2014055647A1
(en)
|
2012-10-03 |
2014-04-10 |
Mei Pharma, Inc. |
(sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
|
|
US9044575B2
(en)
|
2012-10-22 |
2015-06-02 |
Medtronic Adrian Luxembourg S.a.r.l. |
Catheters with enhanced flexibility and associated devices, systems, and methods
|
|
US20150272924A1
(en)
|
2012-11-08 |
2015-10-01 |
Summa Health System |
Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
|
|
US9095321B2
(en)
|
2012-11-21 |
2015-08-04 |
Medtronic Ardian Luxembourg S.A.R.L. |
Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
|
|
AU2013352106B2
(en)
|
2012-11-30 |
2018-04-26 |
Novomedix, Llc |
Substituted biaryl sulfonamides and the use thereof
|
|
EP2928520B1
(de)
|
2012-12-07 |
2019-01-16 |
Cook Medical Technologies LLC |
System zum vermindern von lokalem unwohlsein
|
|
US9169214B2
(en)
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
|
CA2895829A1
(en)
|
2012-12-21 |
2014-06-26 |
Map Pharmaceuticals, Inc. |
Novel methysergide derivatives
|
|
CA2897810A1
(en)
|
2013-01-15 |
2014-07-24 |
A.V. Medical Technologies, Ltd. |
Infusion catheter with guidewire valving
|
|
WO2014126870A1
(en)
*
|
2013-02-12 |
2014-08-21 |
Gary Keeling |
Body cavity drainage device and methods for using the same
|
|
EP2968296B1
(de)
|
2013-03-12 |
2020-09-02 |
The Regents of the University of California |
Gammasekretasemodulatoren
|
|
PL2968880T3
(pl)
|
2013-03-15 |
2025-06-23 |
Taris Biomedical Llc |
Urządzenia do dostarczania leku ze składnikiem przepuszczalnym dla leku
|
|
US9179974B2
(en)
|
2013-03-15 |
2015-11-10 |
Medtronic Ardian Luxembourg S.A.R.L. |
Helical push wire electrode
|
|
EP2996754B1
(de)
|
2013-05-18 |
2023-04-26 |
Medtronic Ardian Luxembourg S.à.r.l. |
Neuromodulationskatheter mit wellen für verbesserter flexibilität und steuerung sowie zugehörige vorrichtungen und systeme
|
|
KR101548046B1
(ko)
*
|
2013-06-05 |
2015-09-04 |
이근호 |
감염 방지구조의 소아용 요도 삽입용 카테타
|
|
SG10201708143QA
(en)
|
2013-06-06 |
2017-11-29 |
Pf Medicament |
Anti-c10orf54 antibodies and uses thereof
|
|
IL299897B2
(en)
|
2013-08-19 |
2024-02-01 |
Taris Biomedical Llc |
Devices and methods for administering multiple units of drug
|
|
CN105683182A
(zh)
|
2013-08-30 |
2016-06-15 |
埃姆比特生物科学公司 |
联芳基乙酰胺化合物及其使用方法
|
|
US20150073515A1
(en)
|
2013-09-09 |
2015-03-12 |
Medtronic Ardian Luxembourg S.a.r.I. |
Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods
|
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
|
WO2015042375A1
(en)
|
2013-09-20 |
2015-03-26 |
Idenix Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US10517892B2
(en)
*
|
2013-10-22 |
2019-12-31 |
Medtronic Minimed, Inc. |
Methods and systems for inhibiting foreign-body responses in diabetic patients
|
|
EP3092026B2
(de)
|
2014-01-08 |
2023-02-15 |
A.V. Medical Technologies, Ltd. |
Vorrichtungen zur bildgebung und behandlung von blutgefässen
|
|
WO2015113034A1
(en)
|
2014-01-27 |
2015-07-30 |
Medtronic Ardian Luxembourg S.A.R.L. |
Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods
|
|
JP2017510328A
(ja)
*
|
2014-02-11 |
2017-04-13 |
オール ケイプ ガイナコロジー エルエルシー |
エンドサイトカニューレ
|
|
EP3450571B1
(de)
|
2014-02-24 |
2023-04-05 |
Celgene Corporation |
Verfahren zur verwendung eines aktivators von cereblon für neuronale zellexpansion und behandlung von erkrankungen des zentralnervensystems
|
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
|
TWI705967B
(zh)
|
2014-03-20 |
2020-10-01 |
美商卡佩拉醫療公司 |
苯并咪唑衍生物及其醫藥組合物及使用方法
|
|
CA3175724C
(en)
|
2014-03-20 |
2024-01-09 |
Capella Therapeutics, Inc. |
Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof
|
|
US10736690B2
(en)
|
2014-04-24 |
2020-08-11 |
Medtronic Ardian Luxembourg S.A.R.L. |
Neuromodulation catheters and associated systems and methods
|
|
EP3142649B1
(de)
|
2014-05-12 |
2019-07-24 |
Conatus Pharmaceuticals, Inc. |
Behandlung der komplikationen von chronischer lebererkrankung mit caspase-inhibitor emricasan
|
|
WO2015179300A1
(en)
|
2014-05-18 |
2015-11-26 |
Awair, Inc. |
Device to reduce discomfort in the upper airway
|
|
DK3148579T3
(da)
|
2014-05-28 |
2021-03-08 |
Agenus Inc |
Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf
|
|
US9527815B2
(en)
|
2014-06-18 |
2016-12-27 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
|
|
US9499514B2
(en)
|
2014-07-11 |
2016-11-22 |
Celgene Corporation |
Antiproliferative compounds and methods of use thereof
|
|
US20160045609A1
(en)
|
2014-08-14 |
2016-02-18 |
Mamoun M. Alhamadsheh |
Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
|
|
JP2017526713A
(ja)
|
2014-09-12 |
2017-09-14 |
トビラ セラピューティクス， インコーポレイテッド |
線維症を処置するためのセニクリビロック併用療法
|
|
EP3209658A1
(de)
|
2014-10-24 |
2017-08-30 |
Biogen MA Inc. |
Diterpenoidderivate und verfahren zur verwendung
|
|
WO2016070107A1
(en)
|
2014-10-31 |
2016-05-06 |
The General Hospital Corporation |
Potent gamma-secretase modulators
|
|
WO2016094837A2
(en)
|
2014-12-11 |
2016-06-16 |
Igenica Biotherapeutics, Inc. |
Anti-c10orf54 antibodies and uses thereof
|
|
EP3789039A1
(de)
|
2014-12-22 |
2021-03-10 |
The Rockefeller University |
Anti-mertk-antikörper und verwendungen davon
|
|
HUE049801T2
(hu)
|
2014-12-23 |
2020-10-28 |
Sma Therapeutics Inc |
3,5-diaminopirazol kináz inhibitorok
|
|
BR112017015510A2
(pt)
|
2015-01-20 |
2018-01-30 |
Xoc Pharmaceuticals Inc |
composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
|
|
CN113149982A
(zh)
|
2015-01-20 |
2021-07-23 |
Xoc制药股份有限公司 |
麦角灵化合物及其用途
|
|
CN107428749B
(zh)
|
2015-01-28 |
2020-07-24 |
上海复旦张江生物医药股份有限公司 |
取代的咪唑并[1,2-α]吡啶-2-基胺化合物及其药物组合物和使用方法
|
|
KR102740384B1
(ko)
|
2015-03-03 |
2024-12-06 |
키맵 리미티드 |
항체, 용도 및 방법
|
|
EP4744688A2
(de)
|
2015-04-23 |
2026-05-20 |
Janssen Biotech Inc |
Arzneimittelabgabevorrichtungen mit arzneimitteldurchlässiger komponente und verfahren
|
|
CA2986765A1
(en)
|
2015-05-29 |
2016-12-08 |
Agenus Inc. |
Anti-ctla-4 antibodies and methods of use thereof
|
|
WO2016210180A2
(en)
|
2015-06-23 |
2016-12-29 |
Neurocrine Biosciences, Inc. |
Vmat2 inhibitors for treating neurological diseases or disorders
|
|
WO2017004265A1
(en)
|
2015-06-30 |
2017-01-05 |
Endologix, Inc. |
Locking assembly for coupling guidewire to delivery system
|
|
US10918827B2
(en)
|
2015-07-20 |
2021-02-16 |
Strataca Systems Limited |
Catheter device and method for inducing negative pressure in a patient's bladder
|
|
US11229771B2
(en)
|
2015-07-20 |
2022-01-25 |
Roivios Limited |
Percutaneous ureteral catheter
|
|
CN112691278B
(zh)
|
2015-07-20 |
2024-03-22 |
罗维奥斯有限公司 |
输尿管和膀胱导管及引入负压以增加肾灌注的方法
|
|
US11541205B2
(en)
|
2015-07-20 |
2023-01-03 |
Roivios Limited |
Coated urinary catheter or ureteral stent and method
|
|
US12064567B2
(en)
|
2015-07-20 |
2024-08-20 |
Roivios Limited |
Percutaneous urinary catheter
|
|
US10765834B2
(en)
|
2015-07-20 |
2020-09-08 |
Strataca Systems Limited |
Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
|
|
US10512713B2
(en)
|
2015-07-20 |
2019-12-24 |
Strataca Systems Limited |
Method of removing excess fluid from a patient with hemodilution
|
|
US10926062B2
(en)
|
2015-07-20 |
2021-02-23 |
Strataca Systems Limited |
Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
|
|
US10493232B2
(en)
|
2015-07-20 |
2019-12-03 |
Strataca Systems Limited |
Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
|
|
US11040180B2
(en)
|
2015-07-20 |
2021-06-22 |
Strataca Systems Limited |
Systems, kits and methods for inducing negative pressure to increase renal function
|
|
US11040172B2
(en)
|
2015-07-20 |
2021-06-22 |
Strataca Systems Limited |
Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
|
|
EP3344656A1
(de)
|
2015-09-01 |
2018-07-11 |
Agenus Inc. |
Anti-pd-1-antikörper und verfahren zur verwendung davon
|
|
IL284874B2
(en)
|
2015-10-30 |
2023-10-01 |
Neurocrine Biosciences Inc |
Valbenazine salts and polymorphs thereof
|
|
WO2017079566A1
(en)
|
2015-11-05 |
2017-05-11 |
Conatus Pharmaceuticals, Inc. |
Caspase inhibitors for use in the treatment of liver cancer
|
|
EP4455145A3
(de)
|
2015-12-02 |
2025-03-12 |
Astraea Therapeutics, LLC |
Piperidinyl-nociceptin-rezeptorverbindungen
|
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
|
LT3394057T
(lt)
|
2015-12-23 |
2022-06-27 |
Neurocrine Biosciences, Inc. |
Sintezės būdas, skirtas pagaminti (s)-(2r,3r,11br)-3-izobutil-9,10-dimetoksi-2,3,4,6,7,11b-heksahidro-1h-pirido[2,1-a]izochinolin-2-ilo 2-amino-3-metilbutanoato di(4-metilbenzensulfonatą)
|
|
EP3397251A1
(de)
|
2015-12-31 |
2018-11-07 |
Conatus Pharmaceuticals, Inc. |
Verfahren zur verwendung von caspase-hemmern bei der behandlung von lebererkrankungen
|
|
EP3399978B1
(de)
|
2016-01-08 |
2020-09-09 |
Celgene Corporation |
Antiproliferative verbindungen und deren pharmazeutische zusammensetzungen und verwendungen
|
|
MX385964B
(es)
|
2016-01-08 |
2025-03-18 |
Celgene Corp |
Formas sólidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il) metil)-2,2-difluoroacetamida y sus composiciones farmacéuticas y usos.
|
|
US10960013B2
(en)
|
2016-03-04 |
2021-03-30 |
East Carolina University |
J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
|
|
WO2017156183A1
(en)
|
2016-03-08 |
2017-09-14 |
Los Gatos Pharmaceuticals, Inc. |
Camptothecin derivatives and uses thereof
|
|
US10064855B2
(en)
|
2016-03-08 |
2018-09-04 |
Los Gatos Pharmaceuticals, Inc. |
Composite nanoparticles and uses thereof
|
|
WO2017180589A1
(en)
|
2016-04-11 |
2017-10-19 |
Auspex Pharmaceuticals, Inc. |
Deuterated ketamine derivatives
|
|
US10047077B2
(en)
|
2016-04-13 |
2018-08-14 |
Skyline Antiinfectives, Inc. |
Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams
|
|
AU2017248837B2
(en)
*
|
2016-04-15 |
2022-02-03 |
Temple University-Of The Commonwealth System Of Higher Education |
Infusion catheter and method of use
|
|
US20170319818A1
(en)
*
|
2016-05-06 |
2017-11-09 |
Cook Medical Technologies Llc |
Drug delivery device
|
|
EP4190357A1
(de)
|
2016-05-13 |
2023-06-07 |
Institut Pasteur |
Hemmung von beta-2-nikotin-acetylcholinrezeptoren zur behandlung von morbus-alzheimer-pathologie
|
|
TWI753910B
(zh)
|
2016-05-16 |
2022-02-01 |
美商拜歐斯瑞克斯公司 |
吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
|
|
MX389710B
(es)
|
2016-05-27 |
2025-03-20 |
Agenus Inc |
Anticuerpos anti proteina inmunoglobulina de linfocitos t y dominio de mucina 3 (tim-3) y métodos para usarlos.
|
|
US10543006B2
(en)
*
|
2016-06-09 |
2020-01-28 |
Boston Scientific Scimed, Inc. |
Infusion catheter
|
|
EP3481864A1
(de)
|
2016-07-08 |
2019-05-15 |
Staten Biotechnology B.V. |
Anti-apoc3-antikörper und verfahren zur verwendung davon
|
|
US10919904B2
(en)
|
2016-08-17 |
2021-02-16 |
North Carolina State University |
Northern-southern route to synthesis of bacteriochlorins
|
|
MX390121B
(es)
|
2016-09-19 |
2025-03-20 |
Mei Pharma Inc |
Combinaciones de un inhibidor de btk y un inhibidor de pi3k para tratar neoplasias malignas hematológicas.
|
|
KR102576042B1
(ko)
|
2016-10-11 |
2023-09-07 |
아게누스 인코포레이티드 |
항-lag-3 항체 및 이의 사용 방법
|
|
US11779604B2
(en)
|
2016-11-03 |
2023-10-10 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
|
|
KR102431830B1
(ko)
|
2016-11-07 |
2022-08-16 |
주식회사 뉴라클사이언스 |
서열 유사성을 가진 항-패밀리 19, 멤버 a5 항체 및 그것의 사용 방법
|
|
WO2018089427A1
(en)
|
2016-11-09 |
2018-05-17 |
Novomedix, Llc |
Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use
|
|
WO2018089692A1
(en)
|
2016-11-09 |
2018-05-17 |
Phloronol, Inc. |
Eckol derivatives, methods of synthesis and uses thereof
|
|
WO2018102252A1
(en)
|
2016-11-30 |
2018-06-07 |
North Carolina State University |
Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
|
|
JP7105774B2
(ja)
|
2016-12-01 |
2022-07-25 |
イグナイタ インコーポレイテッド |
がん治療のための方法
|
|
TW202345829A
(zh)
|
2016-12-02 |
2023-12-01 |
美商紐羅克里生物科學有限公司 |
戊苯那嗪（valbenazine）於治療精神分裂症或情感性精神分裂症之用途
|
|
CN118634323A
(zh)
|
2016-12-07 |
2024-09-13 |
艾吉纳斯公司 |
抗体和其使用方法
|
|
FI3551660T3
(fi)
|
2016-12-07 |
2023-12-11 |
Agenus Inc |
Anti-ctla-4-vasta-aineita ja niiden käyttömenetelmiä
|
|
KR20230169457A
(ko)
|
2017-01-27 |
2023-12-15 |
뉴로크린 바이오사이언시즈 인코퍼레이티드 |
특정 vmat2 억제제의 투여 방법
|
|
CN116730920A
(zh)
|
2017-02-17 |
2023-09-12 |
文涵治疗有限公司 |
Ag-10的制备方法、其中间体及其盐
|
|
AU2018220515B2
(en)
|
2017-02-17 |
2022-06-30 |
DayLife LLC |
Universal antivenom
|
|
WO2018164996A1
(en)
|
2017-03-06 |
2018-09-13 |
Neurocrine Biosciences, Inc. |
Dosing regimen for valbenazine
|
|
KR20190133198A
(ko)
|
2017-03-27 |
2019-12-02 |
셀진 코포레이션 |
면역원성의 감소를 위한 방법 및 조성물
|
|
JP7297672B2
(ja)
|
2017-04-13 |
2023-06-26 |
アジェナス インコーポレイテッド |
抗ｃｄ１３７抗体およびその使用方法
|
|
CA3059133A1
(en)
|
2017-04-21 |
2018-10-25 |
Staten Biotechnology B.V. |
Anti-apoc3 antibodies and methods of use thereof
|
|
US20200179352A1
(en)
|
2017-04-26 |
2020-06-11 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
|
RS64576B1
(sr)
|
2017-05-01 |
2023-10-31 |
Agenus Inc |
Anti-tigit antitela i postupci njihove primene
|
|
JOP20190219A1
(ar)
|
2017-05-09 |
2019-09-22 |
Cardix Therapeutics LLC |
تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية
|
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
|
JP2020522504A
(ja)
|
2017-06-01 |
2020-07-30 |
エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ |
多環式化合物およびそれらの用途
|
|
JP6904616B2
(ja)
|
2017-06-27 |
2021-07-21 |
ニューラクル サイエンス カンパニー リミテッド |
緑内障治療のための配列相同性を有するファミリー、メンバーａ５抗体の用途
|
|
CA3067416A1
(en)
|
2017-06-27 |
2019-01-03 |
Neuracle Science Co., Ltd. |
Use of anti-fam19a5 antibodies for treating cancers
|
|
JP7076059B2
(ja)
|
2017-06-27 |
2022-05-27 |
ニューラクル サイエンス カンパニー リミテッド |
抗ｆａｍ１９ａ５抗体及びその用途
|
|
CN111344011B
(zh)
|
2017-06-27 |
2024-01-26 |
纽洛可科学有限公司 |
抗fam19a5抗体用于治疗纤维化的用途
|
|
US10307566B2
(en)
|
2017-07-05 |
2019-06-04 |
Duke University |
Drainage or infusion catheter and method of use
|
|
WO2019038730A1
(en)
|
2017-08-25 |
2019-02-28 |
Strataca Systems Limited |
REMOTE PUMP FOR FACILITATING ELIMINATION OF URINARY TRACT URINE
|
|
ES2953032T3
(es)
|
2017-09-01 |
2023-11-07 |
Univ East Carolina |
Métodos ex vivo para la activación de las células inmunológicas
|
|
RS66714B1
(sr)
|
2017-09-21 |
2025-05-30 |
Neurocrine Biosciences Inc |
Formulacija visoke doze valbenazina i sastavi, postupci i kompleti povezani sa njim
|
|
CN111263820B
(zh)
|
2017-10-02 |
2024-07-02 |
纽洛可科学有限公司 |
抗序列相似家族19成员a5抗体用于治疗和诊断情绪障碍的用途
|
|
CA3076920A1
(en)
|
2017-10-04 |
2019-04-11 |
The Regents Of The University Of California |
Immunomodulatory oligosaccharides
|
|
KR20250070134A
(ko)
|
2017-10-10 |
2025-05-20 |
뉴로크린 바이오사이언시즈 인코퍼레이티드 |
특정 vmat2 억제제의 투여 방법
|
|
MX2020003421A
(es)
|
2017-10-10 |
2020-07-20 |
Neurocrine Biosciences Inc |
Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2).
|
|
CA3080103A1
(en)
|
2017-10-31 |
2019-05-09 |
Staten Biotechnology B.V. |
Anti-apoc3 antibodies and methods of use thereof
|
|
US20210060299A1
(en)
*
|
2017-12-28 |
2021-03-04 |
Avent, Inc. |
Incisional Tunneler
|
|
AU2019207491A1
(en)
|
2018-01-10 |
2020-07-30 |
Cura Therapeutics, Llc |
Pharmaceutical compositions comprising phenylsulfonamides, and their therapeutic applications
|
|
WO2019139871A1
(en)
|
2018-01-10 |
2019-07-18 |
Cura Therapeutics Llc |
Pharmaceutical compositions comprising dicarboxylic acids and their therapeutic applications
|
|
US11116561B2
(en)
|
2018-01-24 |
2021-09-14 |
Medtronic Ardian Luxembourg S.A.R.L. |
Devices, agents, and associated methods for selective modulation of renal nerves
|
|
MA52137A
(fr)
|
2018-03-23 |
2021-01-27 |
Eidos Therapeutics Inc |
Méthodes de traitement de l'amylose ttr à l'aide d'ag10
|
|
AU2019259798A1
(en)
|
2018-04-24 |
2020-11-12 |
Neuracle Science Co., Ltd. |
Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of neuropathic pain
|
|
CN119662732A
(zh)
|
2018-05-08 |
2025-03-21 |
纽洛可科学有限公司 |
抗fam19a5抗体的腺相关病毒（aav）递送
|
|
KR20240056644A
(ko)
|
2018-05-10 |
2024-04-30 |
주식회사 뉴라클사이언스 |
서열 유사성 19, 멤버 a5 항체를 갖는 항-패밀리 및 그의 사용 방법
|
|
EP3806856A1
(de)
|
2018-06-14 |
2021-04-21 |
Neurocrine Biosciences, Inc. |
Vmat2-inhibitorverbindungen, zusammensetzungen und verfahren im zusammenhang damit
|
|
EP3814327A1
(de)
|
2018-06-29 |
2021-05-05 |
Histogen, Inc. |
(s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorphenoxy)pentansäure-derivate und verwandte verbindungen als caspase-inhibitoren zur behandlung kardiovaskulärer erkrankungen
|
|
IL280199B2
(en)
|
2018-07-20 |
2025-08-01 |
Pf Medicament |
Receptor for vista
|
|
MA53239A
(fr)
|
2018-08-15 |
2022-05-04 |
Neurocrine Biosciences Inc |
Procédés d'administration de certains inhibiteurs de vmat2
|
|
AU2019321583C1
(en)
|
2018-08-17 |
2025-11-27 |
Eidos Therapeutics, Inc. |
Formulations of AG10
|
|
AU2019352017A1
(en)
|
2018-10-03 |
2021-05-06 |
Staten Biotechnology B.V. |
Antibodies specific for human and cynomolgus ApoC3 and methods of use thereof
|
|
AU2019363368A1
(en)
|
2018-10-16 |
2021-05-13 |
Neuracle Science Co., Ltd. |
Use of anti-FAM19A5 antibodies
|
|
US11039914B2
(en)
*
|
2018-10-22 |
2021-06-22 |
Sevro Technologies Llc |
Variable length stent
|
|
CN113365650A
(zh)
|
2018-11-16 |
2021-09-07 |
新免疫技术有限公司 |
用il-7蛋白和免疫检查点抑制剂的组合治疗肿瘤的方法
|
|
WO2020118042A1
(en)
|
2018-12-05 |
2020-06-11 |
Jacobs Wagner Christine |
Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of lyme disease-related pathologies
|
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
|
EP3898609A1
(de)
|
2018-12-19 |
2021-10-27 |
Shy Therapeutics LLC |
Mit der ras-superfamilie interagierende verbindungen zur behandlung von krebs, entzündlichen erkrankungen, rasopathien und fibrotischen erkrankungen
|
|
JP7239216B2
(ja)
|
2018-12-27 |
2023-03-14 |
ニューラクル サイエンス カンパニー リミテッド |
粥状硬化症を治療するための抗ｆａｍ１９ａ５抗体の使用
|
|
CN113195533B
(zh)
|
2019-01-02 |
2024-04-26 |
纽洛可科学有限公司 |
抗序列相似家族19成员a5的抗体及其使用方法
|
|
TWI839461B
(zh)
|
2019-02-06 |
2024-04-21 |
美商戴斯阿爾法股份有限公司 |
Il-17a調節物及其用途
|
|
ES2978570T3
(es)
|
2019-02-26 |
2024-09-16 |
Inspirna Inc |
Anticuerpos anti-MERTK de alta afinidad y sus usos
|
|
WO2020181165A1
(en)
|
2019-03-07 |
2020-09-10 |
Conatus Pharmaceuticals Inc. |
Caspase inhibitors and methods of use thereof
|
|
CN114222802B
(zh)
|
2019-05-20 |
2025-07-11 |
尼尔瓦纳科学股份有限公司 |
窄发射染料、包含其的组合物以及制备和使用其的方法
|
|
JP7754724B2
(ja)
|
2019-05-20 |
2025-10-15 |
ニルバナ サイエンシーズ インク． |
発光波長の範囲が狭い発光染料、それを含む組成物及びそれを製造及び使用する方法
|
|
AU2020311404A1
(en)
|
2019-07-11 |
2022-03-03 |
Cura Therapeutics, Llc |
Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases
|
|
AU2020310190A1
(en)
|
2019-07-11 |
2022-02-24 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
|
US10940141B1
(en)
|
2019-08-23 |
2021-03-09 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
|
KR20220053007A
(ko)
|
2019-08-30 |
2022-04-28 |
아게누스 인코포레이티드 |
항-cd96 항체 및 이의 사용 방법
|
|
JP7566889B2
(ja)
|
2019-09-16 |
2024-10-15 |
ダイス・アルファ・インコーポレイテッド |
Ｉｌ－１７ａモジュレーターおよびその使用
|
|
US20230057939A1
(en)
|
2020-01-13 |
2023-02-23 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and a bispecific antibody
|
|
WO2021151001A1
(en)
|
2020-01-22 |
2021-07-29 |
Outpace Bio, Inc. |
Chimeric polypeptides
|
|
US20230210952A1
(en)
|
2020-02-05 |
2023-07-06 |
Washington University |
Method of treating a solid tumor with a combination of an il-7 protein and car-bearing immune cells
|
|
EP4157271A1
(de)
|
2020-05-29 |
2023-04-05 |
Boulder Bioscience LLC |
Verfahren zur verbesserten endovaskulären thrombektomie mit 3,3'-diindolylmethan
|
|
WO2021257828A1
(en)
|
2020-06-18 |
2021-12-23 |
Shy Therapeutics, Llc |
Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
|
EP4149471A4
(de)
|
2020-06-30 |
2024-07-10 |
Prosetta Biosciences, Inc. |
Isochinolinderivate, verfahren zur synthese und verwendungen davon
|
|
WO2022061348A1
(en)
|
2020-09-16 |
2022-03-24 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
|
TW202231269A
(zh)
|
2020-10-23 |
2022-08-16 |
美商拜歐斯瑞克斯公司 |
Kras蛋白降解劑、其醫藥組合物及其治療應用
|
|
US20240101629A1
(en)
|
2020-11-02 |
2024-03-28 |
Neoimmunetech, Inc. |
Use of interleukin-7 for the treatment of coronavirus
|
|
CN116615236A
(zh)
|
2020-11-05 |
2023-08-18 |
新免疫技术有限公司 |
用il-7蛋白和核苷酸疫苗的组合治疗肿瘤的方法
|
|
AU2021402911A1
(en)
|
2020-12-14 |
2023-07-06 |
Biotheryx, Inc. |
Pde4 degraders, pharmaceutical compositions, and therapeutic applications
|
|
US20240309015A1
(en)
|
2021-01-27 |
2024-09-19 |
Shy Therapeutics, Llc |
Methods for the Treatment of Fibrotic Disease
|
|
US20240124483A1
(en)
|
2021-01-27 |
2024-04-18 |
Shy Therapeutics, Llc |
Methods for the Treatment of Fibrotic Disease
|
|
IL305752A
(en)
|
2021-03-10 |
2023-11-01 |
Dice Molecules Sv Inc |
INTEGRIN INHIBITORS OF ALPHA V BETA 6 AND ALPHA V BETA 1 AND THEIR USES
|
|
WO2022226166A1
(en)
|
2021-04-22 |
2022-10-27 |
Protego Biopharma, Inc. |
Spirocyclic imidazolidinones and imidazolidinediones for treatment of light chain amyloidosis
|
|
CN117615804A
(zh)
*
|
2021-05-07 |
2024-02-27 |
爱惜康股份有限公司 |
具有螺旋元件的负压伤口治疗装置
|
|
EP4347568A1
(de)
|
2021-05-27 |
2024-04-10 |
Protego Biopharma, Inc. |
Heteroaryldiamid-ire1/xbp1s-aktivatoren
|
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
|
JP2024520676A
(ja)
|
2021-06-02 |
2024-05-24 |
ライエル・イミュノファーマ・インコーポレイテッド |
Ｎｒ４ａ３欠損免疫細胞及びその使用
|
|
CA3218481A1
(en)
|
2021-06-14 |
2022-12-22 |
argenx BV |
Anti-il-9 antibodies and methods of use thereof
|
|
WO2022266249A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
|
JP2024522768A
(ja)
|
2021-06-16 |
2024-06-21 |
バイオセリックス， インコーポレイテッド |
Ｓｏｓ１タンパク質分解剤、その医薬組成物及びそれらの治療的応用
|
|
CN113546277B
(zh)
*
|
2021-07-23 |
2022-07-01 |
云南省阜外心血管病医院 |
一种刚度快速调整的医用导管结构
|
|
US12472301B2
(en)
|
2021-08-13 |
2025-11-18 |
3Ive Labs, Llc |
Negative pressure therapy system and methods
|
|
US20240277857A1
(en)
|
2021-09-29 |
2024-08-22 |
Nbios, Inc. |
Coiled-coil fusion protein
|
|
AU2022368836A1
(en)
|
2021-10-22 |
2024-05-02 |
Prosetta Biosciences, Inc. |
Novel host-targeted pan-respiratory antiviral small molecule therapeutics
|
|
KR20240115979A
(ko)
|
2021-11-08 |
2024-07-26 |
프로젠토스 테라퓨틱스, 인크. |
혈소판-유래 성장 인자 수용체(pdgfr) 알파 억제제 및 이의 용도
|
|
EP4456907A1
(de)
|
2021-12-30 |
2024-11-06 |
NeoImmuneTech, Inc. |
Verfahren zur behandlung eines tumors mit einer kombination aus il-7-protein und vegf-antagonist
|
|
JP2025501308A
(ja)
|
2022-01-03 |
2025-01-17 |
ライラック セラピューティクス， インク． |
非環式チオールプロドラッグ
|
|
WO2023129577A1
(en)
|
2022-01-03 |
2023-07-06 |
Lilac Therapeutics, Inc. |
Cyclic thiol prodrugs
|
|
WO2023157989A1
(ko)
|
2022-02-17 |
2023-08-24 |
주식회사 노벨티노빌리티 |
항체-약물 접합체
|
|
JP2025507621A
(ja)
|
2022-03-02 |
2025-03-21 |
ミトパワー， インク． |
ニコチン酸及びリボースから誘導体化した新規プロドラッグ
|
|
WO2023192904A1
(en)
|
2022-03-30 |
2023-10-05 |
Biomarin Pharmaceutical Inc. |
Dystrophin exon skipping oligonucleotides
|
|
GB2619907A
(en)
|
2022-04-01 |
2023-12-27 |
Kanna Health Ltd |
Novel crystalline salt forms of mesembrine
|
|
AR129053A1
(es)
|
2022-04-14 |
2024-07-10 |
Bristol Myers Squibb Co |
Nuevos compuestos gspt1 y métodos de uso de los nuevos compuestos
|
|
AU2023265665A1
(en)
|
2022-05-05 |
2024-10-10 |
Biomarin Pharmaceutical Inc. |
Method of treating duchenne muscular dystrophy
|
|
IL316794A
(en)
|
2022-05-10 |
2025-01-01 |
Biotheryx Inc |
CDK protease inhibitors, pharmaceuticals and therapeutic applications
|
|
KR20250027283A
(ko)
|
2022-05-19 |
2025-02-25 |
라이엘 이뮤노파마, 인크. |
nr4a3을 표적하는 폴리뉴클레오타이드 및 이의 용도
|
|
CN115253019B
(zh)
*
|
2022-08-11 |
2023-06-30 |
临沂市兴华医用器材有限公司 |
一种防损伤的加强型麻醉导管
|
|
JP2025531869A
(ja)
|
2022-09-09 |
2025-09-25 |
イノヴォ セラピューティクス、インコーポレイテッド |
ＣＫ１αおよびＤＵＡＬ ＣＫ１α／ＧＳＰＴ１分解化合物
|
|
EP4593826A1
(de)
|
2022-09-30 |
2025-08-06 |
Boulder Bioscience LLC |
Zusammensetzungen mit 3,3'-diindolylmethan zur behandlung von nichthämorrhagischen verletzungen des geschlossenen kopfes
|
|
JP2025537484A
(ja)
|
2022-10-21 |
2025-11-18 |
ダイアゴナル・セラピューティクス・インコーポレイテッド |
Ｉｌ－１８受容体に対するヘテロマーアゴニスト抗体
|
|
US20240174673A1
(en)
|
2022-10-26 |
2024-05-30 |
Protego Biopharma, Inc. |
Spirocycle Containing Pyridine Compounds
|
|
WO2024092040A1
(en)
|
2022-10-26 |
2024-05-02 |
Protego Biopharma, Inc. |
Spirocycle containing bicyclic heteroaryl compounds
|
|
EP4608838A1
(de)
|
2022-10-26 |
2025-09-03 |
Protego Biopharma, Inc. |
Spirocyclus mit pyridonverbindungen
|
|
KR20250089492A
(ko)
|
2022-11-07 |
2025-06-18 |
네오이뮨텍, 인코퍼레이티드 |
비메틸화된 mgmt 프로모터를 갖는 종양의 치료 방법
|
|
WO2024118810A1
(en)
|
2022-11-30 |
2024-06-06 |
Protego Biopharma, Inc. |
Cyclic pyrazole diamide ire1/xbp1s activators
|
|
EP4626864A1
(de)
|
2022-11-30 |
2025-10-08 |
Protego Biopharma, Inc. |
Lineare heteroaryldiamid-ire1/xbp1s-aktivatoren
|
|
WO2024194685A2
(en)
|
2023-03-17 |
2024-09-26 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
AU2024240129A1
(en)
|
2023-03-17 |
2025-10-09 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
AU2024254039A1
(en)
|
2023-04-07 |
2025-10-02 |
Diagonal Therapeutics Inc. |
Hinge-modified bispecific antibodies
|
|
EP4688147A1
(de)
|
2023-04-07 |
2026-02-11 |
Diagonal Therapeutics Inc. |
Bispezifische agonistische antikörper gegen activin a rezeptor-ähnliches typ 1 (alk1)
|
|
WO2024226471A2
(en)
|
2023-04-24 |
2024-10-31 |
Biomarin Pharmaceutical Inc. |
Compositions and methods for treating stxbp1 disorders
|
|
TW202448485A
(zh)
|
2023-05-05 |
2024-12-16 |
美商拜奧馬林製藥公司 |
肌萎縮蛋白外顯子跳躍寡核苷酸
|
|
EP4709725A1
(de)
|
2023-05-09 |
2026-03-18 |
Progentos Therapeutics, Inc. |
Heterocyclische verbindungen und verwendungen davon
|
|
AU2024276812A1
(en)
|
2023-05-19 |
2025-11-06 |
Diagonal Therapeutics Inc. |
Bispecific agonistic antibodies to il12 receptor
|
|
KR20260033048A
(ko)
|
2023-07-03 |
2026-03-10 |
네오이뮨텍, 인코퍼레이티드 |
이종이합체 fc 분자 및 이의 용도
|
|
WO2025046298A2
(en)
|
2023-09-01 |
2025-03-06 |
iTeos Belgium SA |
Anti-trem2 antibodies and methods of use
|
|
AU2024344247A1
(en)
|
2023-09-19 |
2026-05-07 |
Kancure Pte. Ltd. |
Survivin-targeted compounds
|
|
IL327069A
(en)
|
2023-09-27 |
2026-05-01 |
Isosterix Inc |
Mist inhibitors
|
|
WO2025085416A1
(en)
|
2023-10-16 |
2025-04-24 |
Bristol-Myers Squibb Company |
Gspt1 compounds and methods of use of the compounds
|
|
AU2024366926A1
(en)
|
2023-10-23 |
2026-03-12 |
Diagonal Therapeutics Inc. |
Heteromeric agonistic antibodies to il-18 receptor
|
|
GB2636969A
(en)
|
2023-11-24 |
2025-07-09 |
Ontrack Therapeutics Ltd |
Novel crystalline salt forms
|
|
WO2025133707A1
(en)
|
2023-12-19 |
2025-06-26 |
Vectory Therapeutics B.V. |
Anti-tdp-43 antibodies and uses thereof
|
|
WO2025147691A1
(en)
|
2024-01-04 |
2025-07-10 |
Innovo Therapeutics, Inc. |
Compositions and methods for degrading aryl hydrocarbon receptor nuclear translocator protein
|
|
WO2025179161A1
(en)
|
2024-02-21 |
2025-08-28 |
Innovo Therapeutics, Inc. |
Protein degrading compounds
|
|
WO2025201633A1
(en)
|
2024-03-26 |
2025-10-02 |
Chen Gefei |
An agent for reducing amyloid formation
|
|
US20260069759A1
(en)
*
|
2024-04-17 |
2026-03-12 |
Theradrain Ltd. |
Vacuum based system and method for treating a gastrointestinal tract of a subject
|
|
WO2025255341A1
(en)
|
2024-06-05 |
2025-12-11 |
Protego Biopharma, Inc. |
Tetrahydrofuranyl ire1/xbp1s activators
|
|
WO2026080748A2
(en)
|
2024-10-09 |
2026-04-16 |
Diagonal Therapeutics Inc. |
Bone morphogenetic protein receptor type 2 (bmprii) antibodies
|
|
WO2026080757A2
(en)
|
2024-10-09 |
2026-04-16 |
Diagonal Therapeutics Inc. |
Activin receptor type ii a/b (actriia/b) antibodies
|
|
WO2026080752A2
(en)
|
2024-10-09 |
2026-04-16 |
Diagonal Therapeutics Inc. |
De novo antibodies to activin a receptor like type 1 (alk1)
|